Strongly adhesive injectable hyaluronic acid double network hydrogel and preparation method thereof
The hyaluronic acid cross-linking technology grafted by thiolated hyaluronic acid and maleimidized polyethylene glycol and dopamine is formed, which solves the difficulty of fiber ring occluder to meet the biomechanical characteristics of fiber ring occluder. Problem, high strength and strong adhesion are achieved, meeting the filling and repair needs of fiber annulus.
Patent Information
- Application Number
- CN202211601157.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-13
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2042-12-13
AI Technical Summary
The existing fiber annular occluders are difficult to meet the unique biomechanical characteristics of fiber annular anisotropy, nonlinearity, viscoelasticity, etc., and the mechanical properties and anti-enzyme degradation properties of natural hyaluronic acid hydrogels are insufficient, making it difficult to be in the body for a long time. Stable filling and repair of fibrocyclic defects.
The cross-linking of thiolated hyaluronic acid and maleimidized polyethylene glycol is used as the first layer network, and the self-oxidation cross-linking of hyaluronic acid through dopamine-grafted hyaluronic acid is used as the second layer network to form a strong adhesion injectable hyaluronic acid double network hydrogel improves its mechanical properties and biocompatibility.
It realizes the high strength and super adhesion of dual network hydrogels, can effectively fill and seal the fiber annulus defects, and has certain pro-repair effects to meet the biocompatibility needs of clinical applications.
Smart Images

Figure CN116139334B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical polymer materials, and in particular relates to a strongly-adhesive injectable hyaluronic acid double-network hydrogel and a preparation method thereof. Background Art
[0002] The methods of repairing annulus fibrosus defects include direct suture repair technology and tissue engineering scaffold repair technology. The former can complete the physical occlusion of the annulus fibrosus and prevent the nucleus pulposus from herniating again, but it cannot restore the internal structure and mechanical characteristics of the annulus fibrosus of the intervertebral disc, nor can it promote the regeneration of the intervertebral disc, and it is difficult to meet the needs of biological repair. Tissue engineering technology has developed rapidly in recent years and has achieved good results in the biological repair of various tissues. Therefore, it has been introduced into the field of annulus fibrosus repair and has made certain progress.
[0003] Pirvu et al. [Biomaterials, 2015, 42, 11-19] constructed a polytrimethylene carbonate scaffold and implanted BMSCs to repair an in vitro organ culture bovine annulus defect model. The results showed that the cell-scaffold complex can effectively prevent the protrusion of nucleus pulposus tissue. Another study [European Cells & Materials, 2014, 28, 25] found that genipin / fibrin composite materials have good biochemical and biomechanical properties and are expected to be used as cell carriers for annulus defect plugging agents or promoting annulus regeneration. Grunert et al. [Spine, 2014, 39, 198] used high-density type I collagen cross-linked with riboflavin to form a fiber cap locally, successfully plugging the defect site and effectively preventing intervertebral disc degeneration. The above studies suggest that current biomaterials can effectively fill annulus defects. However, the tissue engineering scaffolds for annulus fibrosus repair must not only meet the general properties such as good biocompatibility, non-toxicity to cells and human body, and degradability, but also meet the unique biomechanical characteristics of the annulus fibrosus such as anisotropy, nonlinearity, and viscoelasticity.
[0004] As an emerging biomaterial in the field of intervertebral disc repair in recent years, hydrogel has a three-dimensional cross-linked network structure, adjustable physical and chemical properties and extracellular matrix-like characteristics, and can be used for cell adhesion and proliferation. The design concept of hydrogel integrates the structural integrity, biocompatibility, biodegradability, safety, solute transport, mechanical strength and viscosity of the implant. By selecting different hydrogel component types, cross-linking methods, and modification methods, hydrogels exhibit a variety of composite functions as filling implants. For example, patent CN201710327534.9 discloses a dynamic cross-linked double network hydrogel and its preparation method and application, wherein the dynamic cross-linked double network hydrogel is formed by interlacing and entanglement of a main network and a secondary network in an aqueous medium; the main network is a dynamic covalently cross-linked polymer; the secondary network is an ionic cross-linked polymer; 30 covalently cross-linked polymers are formed by covalently cross-linking polymers A and B; ionic cross-linked polymers
[0005] The material is formed by cross-linking polymer C and ionic compounds through ionic bonds. Patent CN202010914794.8 discloses a CHI-HA / SH4-PEG gel, which is made by the following five steps: (1) dissolving hyaluronic acid,
[0006] (2) CHI-HA synthesis reaction, (3) dialysis drying, (4) CHI-HA dissolution, (5) CHI-
[0007] HA / SH4-PEG synthesis reaction.
[0008] 35 As one of the most important components of the natural extracellular matrix (ECM), hyaluronic acid (HA) is
[0009] One of the most attractive biomacromolecules. Due to its excellent biocompatibility, biodegradability and non-immunogenicity, HA is an extremely attractive raw material for preparing hydrogels with ideal structure, strength and biocompatibility.
[0010] However, the HA gel formed by physical cross-linking cannot have 40% long-lasting mechanical properties, and HA has poor resistance to enzyme degradation and will degrade quickly in the body.
[0011] In order to improve the mechanical properties of HA hydrogels and extend their degradation cycle, covalent cross-linking becomes a necessary choice.
[0012] The presence of a large number of hydroxyl and carboxyl groups in the hydrogel facilitates its chemical crosslinking. Without modifying the natural HA, crosslinking agents such as diepoxides, divinyl sulfone derivatives, and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) can be directly added for crosslinking. Compared with natural HA, the 45 covalently crosslinked gel exhibits stronger mechanical properties and better resistance to enzyme degradation. However, the chemical reactions of direct crosslinking of natural HA to form hydrogels require very harsh reaction conditions, and the crosslinking agents are toxic, which will more or less cause harm to living organisms. For biomedical applications such as tissue engineering, the reaction to form HA hydrogels must be efficient and selective under physiological conditions.
[0013] It occurs selectively without any additional conditions and without producing any toxic byproducts, so chemical modification of HA becomes a necessary prerequisite.
[0014] Polyethylene glycol (PEG) is stable in nature, has good water solubility, is non-toxic, non-irritating, and non-antigenic. Its excellent biocompatibility has been certified by the U.S. Food and Drug Administration (FDA). It is a biofriendly synthetic polymer. The safety of PEG as a biomaterial has been long-standing.
[0015] The molecular weight of PEG is relatively wide, and its molecular weight can be adjusted to improve the performance of the hydrogel to meet various needs.
[0016] Dopamine can undergo oxidative self-polymerization under weak alkaline conditions to produce an environmentally friendly biomacromolecule polydopamine (PDA). In the process of forming polydopamine, dopamine undergoes oxidative self-polymerization while forming relatively strong covalent and non-covalent bonds with the interface of almost all substrates.
[0017] After polydopamine adheres to the substrate surface, it can introduce highly reactive and hydrophilic phenol, imino and indole-like functional groups on the substrate surface, thereby imparting
[0018] It provides a secondary functional platform for the substrate.
[0019] Currently, there is an urgent need to provide a double-network hyaluronic acid hydrogel with higher strength and stronger adhesion. Summary of the invention
[0020] In view of the fact that existing annular fiber occluders are difficult to meet the unique biomechanical characteristics of the annular fiber, such as anisotropy, nonlinearity, and viscoelasticity, the present invention provides a strongly adhesive injectable hyaluronic acid double network hydrogel and
[0021] The key to the invention is to design a cross-linking scheme for hyaluronic acid, cross-linking thiolated hyaluronic acid with maleimidized polyethylene glycol as the first layer of hyaluronic acid cross-linking network, and self-oxidative cross-linking of dopamine-grafted hyaluronic acid as the second layer of hyaluronic acid cross-linking network, and then studying the double network
[0022] The double network hydrogel obtained by the above method has strong mechanical properties and super strong adhesion, which can effectively fill and
[0023] The defect of the annulus fibrosus is blocked and has a certain effect of promoting repair. The hydrogel annulus fibrosus occluder prepared by the double network hyaluronic acid has good biocompatibility and can meet the needs of clinical application.
[0024] In order to achieve the above-mentioned object of the invention, the technical solution of the present invention is as follows:
[0025] On the one hand, the present invention provides a strong adhesion injectable hyaluronic acid double network hydrogel, wherein the hydrogel has maleimide PEG cross-linked thiolated HA as the first layer of hyaluronic acid cross-linked network.
[0026] The hyaluronic acid grafted with dopamine is cross-linked through the oxidative self-polymerization of dopamine as the second layer of hyaluronic acid cross-linking network.
[0027] In another aspect, the present invention provides a method for preparing the above hydrogel, the method comprising the following steps:
[0028] 80S1. Synthesis of thiolated hyaluronic acid HA-SH;
[0029] S2. Synthesis of PEG crosslinker MAL-PEG-MAL;
[0030] S3. Synthesis of dopamine-modified hyaluronic acid HA-DA;
[0031] S4. Synthesis of strongly adhesive injectable double-network hyaluronic acid hydrogel.
[0032] Specifically, the step S1 comprises the following steps: dissolving hyaluronic acid in deionized water, adding 85 carbodiimide and N-hydroxysuccinimide, adjusting the pH to acidic, reacting for 1-3 hours, adding cysteine hydrochloride,
[0033] Amine, after reacting for 36-72 hours, dithiothreitol is added, and the above mixture is reacted under nitrogen protection for 20-28 hours, the pH is adjusted to acidic, dialyzed, the pH of the solution is adjusted to neutral, and it is quickly placed in liquid nitrogen for cooling, and freeze-dried to obtain white foamy thiolated hyaluronic acid HA-SH.
[0034] More specifically, the mass average molecular weight of the hyaluronic acid HA is in the range of 100,000-300,000 g / mol.
[0035] More specifically, the molar ratio of cysteamine hydrochloride to HA is 1000 / 1-5000 / 1.
[0036] More specifically, the molar ratio of dithiothreitol to HA is 10000 / 1-50000 / 1.
[0037] Specifically, the step S2 comprises the following steps: 1) Synthesis of N-glycine maleamic acid: glycine and maleic anhydride are placed in glacial acetic acid, and N-glycine maleamic acid is prepared by reaction; 2) Synthesis of N-glycine maleimide: the above N-glycine maleamic acid is placed in toluene, triethylamine is added, refluxed, and vacuum rotary evaporation is performed to prepare triethylamine salt of solid N-glycine maleimide, which is dissolved in a solution with a pH of 2, and extracted with ethyl acetate. , vacuum drying to prepare N-glycine maleimide; 3) Maleimide modification of linear PEG end groups: N-glycine maleimide, N,N-dicyclohexylcarbodiimide and 4-dimethylaminopyridine were added to a dichloromethane solution of PEG, and the dichloromethane was removed by vacuum rotary evaporation after the reaction. The sample was dissolved in isopropanol, and the solid was collected after standing. The solid was washed with isopropanol and ether, and the PEG crosslinker MAL-PEG-MAL was obtained after vacuum drying.
[0038] More specifically, the molar ratio of glycine to maleic anhydride is 1 / 1-1 / 1.5.
[0039] More specifically, the molar ratio of triethylamine to N-glycine maleamic acid is 3 / 1-1 / 1.
[0040] More specifically, the molar ratio of N-glycine maleimide, N,N-dicyclohexylcarbodiimide, 4-dimethylaminopyridine and PEG is 2.5 / 3.0 / 0.1 / 0.25.
[0041] More specifically, the mass average molecular weight of the PEG is in the range of 5000-15000 g / mol.
[0042] Specifically, the step S3 includes the following steps: dissolving hyaluronic acid HA in MES buffer solution, stirring at room temperature until completely dissolved, then adding carbodiimide and N-hydroxysuccinimide to the above solution, adjusting the pH value of the solution to acidic, continuing to stir the reaction, adding dopamine hydrochloride, adding MES buffer dropwise, stirring at room temperature overnight under nitrogen protection, maintaining the pH value at weak acidity, then dialyzing the mixed solution in acidic deionized water to purify and remove unreacted dopamine hydrochloride, and finally freeze-drying to obtain a white flocculent grafted product, i.e., dopamine-modified hyaluronic acid HA-DA, which is stored in a refrigerator.
[0043] More specifically, the molar ratio of dopamine hydrochloride to HA is 500 / 1-300 / 1.
[0044] Specifically, the step S4 comprises the following steps: adding the above-mentioned MAL-PEG-MAL crosslinker to HA-SH to obtain a hydrogel HA-SH-MAL-PEG-MAL composed of HA / PEG, and then adding the HA-DA solution to the above-mentioned hydrogel, stirring to fully dissolve it, and then standing it for crosslinking.
[0045] More specifically, the mass ratio of HA-SH / MAL-PEG-MAL is 1 / 1-10 / 1.
[0046] More specifically, the mass ratio of HA-SH-MAL-PEG-MAL / HA-DA is 0.5 / 1-2 / 1.
[0047] In certain embodiments, the method for preparing the hydrogel of the present invention comprises the following steps:
[0048] (1) Synthesis of thiolated hyaluronic acid
[0049] First, a certain amount of hyaluronic acid (HA) was weighed and dissolved in deionized water, and 3 times the molar mass of carbodiimide (EDC) and N-hydroxysuccinimide (NHS) were added to the above solution, and HCl was added to adjust the pH of the solution to acidic. Cysteamine hydrochloride was added after two hours of reaction. NaOH was added after 2 days of reaction to terminate the reaction. Then dithiothreitol (DTT) was dissolved in water and added to the above mixed solution. After the above mixture was reacted under nitrogen protection for 24 hours, HCl was added to adjust the pH value of the mixed solution to acidic. The above solution was dialyzed with a dialysis bag. After dialysis, the pH of the solution was adjusted to neutral with NaOH, and then it was quickly placed in liquid nitrogen for cooling. Finally, freeze-dried to obtain white foamy thiolated hyaluronic acid (HA-SH).
[0050] (2) Synthesis of PEG cross-linker
[0051] 1) Synthesis of N-glycine maleamic acid. Weigh a certain mass of glycine and maleic anhydride and place them in a 500 mL round-bottom flask, and add 200 mL of glacial acetic acid. After magnetic stirring at 30°C for 3 hours, filter under reduced pressure and wash the solid with cold water. After vacuum drying, white solid N-glycine maleamic acid is obtained. 2) Synthesis of N-glycine maleimide. Weigh a certain mass of N-glycine maleamic acid and place it in 300 mL of toluene, and add triethylamine. The mixture is refluxed for a period of time, and the water generated by the reaction is removed by a Dean-Stark device. After the reaction is completed, cool to room temperature and pour out the toluene solution, remove toluene by vacuum rotary evaporation, and obtain the triethylamine salt of solid N-glycine maleimide. Dissolve the solid in 100 mL of water with pH = 2 (pH adjusted with hydrochloric acid), extract with ethyl acetate 3 times, 50 mL each time, and vacuum dry to obtain N-glycine maleimide solid. 3) Maleimide modification of linear PEG end groups. Add N-glycine maleimide, N,N-dicyclohexylcarbodiimide and 4-dimethylaminopyridine to 30 mL of dichloromethane solution of PEG. After one day of magnetic stirring at room temperature, the filtrate was collected by filtration and dichloromethane was removed by vacuum rotary evaporation. The sample obtained after the solution was removed was dissolved in isopropanol, allowed to stand at 4°C for 3 hours, and the precipitated solid was collected by vacuum filtration and washed with isopropanol and ether respectively. Maleimide PEG can be obtained after vacuum drying.
[0052] (3) Synthesis of dopamine-modified hyaluronic acid
[0053] Dissolve HA in 100 mL MES buffer solution and stir at room temperature until completely dissolved. Then add EDC and NHS to the above solution, adjust the pH value of the solution to acidic, continue stirring and reacting for 30 minutes, add dopamine hydrochloride, add 10 mL MES buffer dropwise, stir overnight at room temperature under nitrogen protection, and maintain the pH value at weak acidity. Then dialyze and purify the mixture in acidic deionized water in a dialysis bag for 3 days to remove unreacted dopamine hydrochloride, and finally freeze-dry for 48 hours to obtain a white flocculent grafted product, which is dopamine-modified hyaluronic acid (HA-DA), and store it in a refrigerator.
[0054] (4) Synthesis of highly adhesive injectable double-network hyaluronic acid hydrogel
[0055] Since maleimide and thiol can easily form stable thioether bonds at pH = 6.5-7.5, maleimide PEG can be used to crosslink thiolated HA as the first layer of hyaluronic acid crosslinking network. Dopamine can be oxidized and self-polymerized to form polydopamine. The oxidation process can form relatively strong covalent bonds and non-covalent bonds with almost all substrates. Therefore, hyaluronic acid grafted with dopamine can be used as the second layer of hyaluronic acid crosslinking network through the oxidation and self-polymerization of dopamine. Double network hyaluronic acid hydrogels are prepared according to the following steps, respectively, with PBS to prepare different concentrations of HA-SH solution, crosslinker MAL-PEG-MAL solution and HA-DA solution. First, the MAL-PEG-MAL crosslinker is added to HA-SH to obtain hydrogels of different concentrations of HA / PEG, and then the HA-DA solution is added to the above hydrogel, stirred to fully dissolve, and then allowed to stand for crosslinking.
[0056] Compared with the prior art, the present invention has the following positive and beneficial effects:
[0057] (1) The present invention provides a strong adhesive injectable hyaluronic acid double network hydrogel, which uses maleimidized PEG cross-linked thiolated HA as the first layer of hyaluronic acid cross-linked network, and uses hyaluronic acid grafted with dopamine as the second layer of hyaluronic acid cross-linked network through dopamine oxidation self-polymerization cross-linked hyaluronic acid, to obtain a double network hyaluronic acid hydrogel with high strength and adhesion that truly meets the annulus fibrosus occlusion function. The application of this idea will have high research significance and application value in the field of biodegradable annulus fibrosus occluders.
[0058] (2) The key to the preparation method of the present invention is to design the cross-linking scheme of hyaluronic acid, cross-linking thiolated hyaluronic acid with maleimidized polyethylene glycol as the first layer of hyaluronic acid cross-linking network, and self-oxidation cross-linking of dopamine-grafted hyaluronic acid as the second layer of hyaluronic acid cross-linking network, and then studying the adhesion and physicochemical properties of the double-network hyaluronic acid hydrogel and the repair effect on the annulus fibrosus. The double-network hydrogel obtained by the above method has strong mechanical properties and super strong adhesion, can effectively fill and block the annulus fibrosus defects, and has a certain promoting repair effect. The hydrogel annulus fibrosus occluder prepared by the double-network hyaluronic acid has good biocompatibility and can meet the needs of clinical application. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] Figure 1 Schematic diagram of the synthesis route of the double-network hyaluronic acid hydrogel prepared in Example 1.
[0060] Figure 2 This is a dynamic frequency scanning curve diagram of the double-network hyaluronic acid hydrogel prepared in Example 1.
[0061] Figure 3This is a graph showing the adhesion experiment of the double-network hyaluronic acid hydrogel prepared in Example 1.
[0062] Figure 4 This is a live-dead staining experiment result of mouse annulus fibrosus cells cultured on the double-network hyaluronic acid hydrogel prepared in Example 1 for 48 hours.
[0063] Figure 5 This is a dynamic frequency scanning curve diagram of the double-network hyaluronic acid hydrogel prepared in Example 2.
[0064] Figure 6 This is a dynamic frequency scanning curve diagram of the double-network hyaluronic acid hydrogel prepared in Example 3.
[0065] Figure 7 This is a dynamic frequency scanning curve diagram of the double-network hyaluronic acid hydrogel prepared in Example 4. DETAILED DESCRIPTION
[0066] The present invention will be further described in detail below in conjunction with specific examples. The following examples are not intended to limit the present invention, but are only intended to illustrate the present invention. The experimental methods used in the following examples are generally conventional, unless otherwise specified, and the materials, reagents, etc. used in the following examples are commercially available, unless otherwise specified.
[0067] Example 1.
[0068] First, 200 mg HA was dissolved in 20 ml water, and EDAC (287 mg, 1.5 mmol) and NHS (172 mg, 1.5 mmol) with 3 times the molar mass (compared to the carboxylic acid group in HA) were added to the above solution, and 4 M HCl was added to adjust the pH of the solution to 4-5. After two hours of reaction, 337 mg, 1.5 mmol of cysteamine hydrochloride was added. After two days of reaction, 4 M NaOH was added to terminate the reaction. Then 2.3 g, 15 mmol of DTT was dissolved in 5 ml of water and added to the above mixed solution. After the above mixture was reacted under nitrogen protection for 24 hours, 4 M HCl was added to adjust the pH value of the mixed solution to 5. The above solution was dialyzed with a 12000 molecular weight dialysis bag, and the dialyzate was a HCl (pH = 5) solution containing 4 g / l NaCl. After dialysis, the pH of the solution was adjusted to 7 with 1 M NaOH, and then it was quickly placed in liquid nitrogen for cooling. Finally, white foamy thiolated hyaluronic acid (HA-SH) was obtained by freeze drying.
[0069] 1) Synthesis of N-glycine maleamic acid. Glycine (10 g, 0.13 mol) and maleic anhydride (15.68 g, 0.16 mol) were placed in a 500 mL round-bottom flask and 200 mL of glacial acetic acid was added. After magnetic stirring at 30 ° C for 3 h, the mixture was filtered under reduced pressure and the solid was washed with cold water. After vacuum drying, white solid N-glycine maleamic acid was obtained. 2) Synthesis of N-glycine maleimide. N-glycine maleamic acid (10 g, 0.057 mol) was placed in 300 mL of toluene and triethylamine (12.22 g, 0.12 mol) was added. The mixture was refluxed for 2.5 h, and the water generated by the reaction was removed by a Dean-Stark apparatus. After the reaction was completed, the toluene solution was cooled to room temperature and decanted, and the toluene was removed by vacuum rotary evaporation to obtain the triethylamine salt of solid N-glycine maleimide. The solid was dissolved in 100 mL of water at pH = 2 (pH adjusted with hydrochloric acid), extracted with ethyl acetate 3 times, 50 mL each time, and vacuum dried to obtain N-glycine maleimide solid. 3) Maleimide modification of linear PEG end groups. N-glycine maleimide (0.39 g, 2.5 mmol), N,N-dicyclohexylcarbodiimide (0.62 g, 3.0 mmol) and 4-dimethylaminopyridine (0.012 g, 0.1 mmol) were added to a 30 mL dichloromethane solution of PEG10K (1 g, 0.25 mmol). After magnetic stirring for 24 h at room temperature, the filtrate was collected by filtration and the dichloromethane was removed by vacuum rotary evaporation. The sample obtained after the solution was removed was dissolved in isopropanol (30 mL), allowed to stand at 4 ° C for 3 h, and the precipitated solid was collected by vacuum filtration, and the solid was washed with isopropanol and ether respectively. Maleimide PEG (MAL-PEG-MAL) can be obtained after vacuum drying.
[0070] Dissolve 1g HA in 100mL MES buffer solution (0.1M, pH4.7) and stir at room temperature until completely dissolved. Then add 0.474g EDC and 0.285g NHS to the above solution, adjust the pH value of the solution to 5, continue stirring and reacting for 30 minutes, add 0.388g dopamine hydrochloride, add 10mL MES buffer (0.1M, pH5.5) dropwise, stir overnight at room temperature under nitrogen protection, and maintain the pH value at about 5.5. Then, the mixed solution is dialyzed and purified in acidic deionized water in a MWCO3500 dialysis bag for 3 days to remove unreacted dopamine hydrochloride, and finally freeze-dried for 48 hours to obtain a white flocculent grafted product, which is dopamine-modified hyaluronic acid (HA-DA).
[0071] The double network hyaluronic acid hydrogel was prepared according to the following steps: 10wt% HA-SH solution, 6wt% crosslinker MAL-PEG-MAL solution and 10wt% HA-DA solution were prepared with PBS. First, the MAL-PEG-MAL crosslinker was added to HA-SH to obtain a hydrogel composed of HA / PEG, and then the HA-DA solution was added to the above hydrogel, stirred to fully dissolve, and then allowed to stand for crosslinking.
[0072] in, Figure 1 Schematic diagram of the synthesis route of the double-network hyaluronic acid hydrogel prepared in Example 1.
[0073] Figure 2 This is the dynamic frequency scanning curve of the double network hyaluronic acid hydrogel prepared in Example 1. The storage modulus (G') and loss modulus (G") of the hydrogel show frequency-dependent behavior, which is a typical feature of dynamic hydrogels. The hydrogel exhibits liquid-like behavior at low frequencies, with G' being less than G", however, the hydrogel shows a solid state with G' being greater than G" at high frequencies. Its storage modulus is 6500Pa.
[0074] Figure 3 This is an adhesion experiment of the double network hyaluronic acid hydrogel prepared in Example 1. The presence of catechol gives the double network hyaluronic acid hydrogel special adhesive properties. Figure 3 As shown, the double-network hyaluronic acid hydrogel can adhere to human skin without tissue irritation or inflammatory response to the skin, and can also adhere to metal weights and plastic centrifuge tubes filled with water.
[0075] Figure 4 The live-dead staining experiment results of mouse annulus fibrosus cells after 48 hours of culture on the double network hyaluronic acid hydrogel prepared in Example 1. Similar to the control group, after 48 hours of culture, most of the annulus fibrosus cells survived (green) on the double network hyaluronic acid hydrogel, and there were almost no dead cells (red). This shows that the double network hyaluronic acid hydrogel has good cell compatibility and allows the annulus fibrosus cells to survive and proliferate.
[0076] Example 2
[0077] First, 200 mg HA was dissolved in 20 ml water, and EDAC (287 mg, 1.5 mmol) and NHS (172 mg, 1.5 mmol) with 3 times the molar mass (compared to the carboxylic acid group in HA) were added to the above solution, and 4 M HCl was added to adjust the pH of the solution to 4-5. After two hours of reaction, 337 mg, 1.5 mmol of cysteamine hydrochloride was added. After two days of reaction, 4 M NaOH was added to terminate the reaction. Then 2.3 g, 15 mmol of DTT was dissolved in 5 ml of water and added to the above mixed solution. After the above mixture was reacted under nitrogen protection for 24 hours, 4 M HCl was added to adjust the pH value of the mixed solution to 5. The above solution was dialyzed with a 12000 molecular weight dialysis bag, and the dialyzate was a HCl (pH = 5) solution containing 4 g / l NaCl. After dialysis, the pH of the solution was adjusted to 7 with 1 M NaOH, and then it was quickly placed in liquid nitrogen for cooling. Finally, white foamy thiolated hyaluronic acid (HA-SH) was obtained by freeze drying.
[0078] 1) Synthesis of N-glycine maleamic acid. Glycine (10 g, 0.13 mol) and maleic anhydride (15.68 g, 0.16 mol) were placed in a 500 mL round-bottom flask and 200 mL of glacial acetic acid was added. After magnetic stirring at 30 ° C for 3 h, the mixture was filtered under reduced pressure and the solid was washed with cold water. After vacuum drying, white solid N-glycine maleamic acid was obtained. 2) Synthesis of N-glycine maleimide. N-glycine maleamic acid (10 g, 0.057 mol) was placed in 300 mL of toluene and triethylamine (12.22 g, 0.12 mol) was added. The mixture was refluxed for 2.5 h, and the water generated by the reaction was removed by a Dean-Stark apparatus. After the reaction was completed, the toluene solution was cooled to room temperature and decanted, and the toluene was removed by vacuum rotary evaporation to obtain the triethylamine salt of solid N-glycine maleimide. The solid was dissolved in 100 mL of water at pH = 2 (pH adjusted with hydrochloric acid), extracted with ethyl acetate 3 times, 50 mL each time, and vacuum dried to obtain N-glycine maleimide solid. 3) Maleimide modification of linear PEG end groups. N-glycine maleimide (0.39 g, 2.5 mmol), N,N-dicyclohexylcarbodiimide (0.62 g, 3.0 mmol) and 4-dimethylaminopyridine (0.012 g, 0.1 mmol) were added to a 30 mL dichloromethane solution of PEG10K (1 g, 0.25 mmol). After magnetic stirring for 24 h at room temperature, the filtrate was collected by filtration and the dichloromethane was removed by vacuum rotary evaporation. The sample obtained after the solution was removed was dissolved in isopropanol (30 mL), allowed to stand at 4 ° C for 3 h, and the precipitated solid was collected by vacuum filtration, and the solid was washed with isopropanol and ether respectively. Maleimide PEG (MAL-PEG-MAL) can be obtained after vacuum drying.
[0079] Dissolve 1g HA in 100mL MES buffer solution (0.1M, pH4.7) and stir at room temperature until completely dissolved. Then add 0.474g EDC and 0.285g NHS to the above solution, adjust the pH value of the solution to 5, continue stirring and reacting for 30 minutes, add 0.388g dopamine hydrochloride, add 10mL MES buffer (0.1M, pH5.5) dropwise, stir overnight at room temperature under nitrogen protection, and maintain the pH value at about 5.5. Then, the mixed solution is dialyzed and purified in acidic deionized water in a MWCO3500 dialysis bag for 3 days to remove unreacted dopamine hydrochloride, and finally freeze-dried for 48 hours to obtain a white flocculent grafted product, which is dopamine-modified hyaluronic acid (HA-DA).
[0080] The double network hyaluronic acid hydrogel was prepared according to the following steps: 10wt% HA-SH solution, 6wt% crosslinker MAL-PEG-MAL solution and 5wt% HA-DA solution were prepared with PBS. First, the MAL-PEG-MAL crosslinker was added to HA-SH to obtain a hydrogel composed of HA / PEG, and then the HA-DA solution was added to the above hydrogel, stirred to fully dissolve, and then allowed to stand for crosslinking.
[0081] Figure 5 This is the dynamic frequency scanning curve of the double network hyaluronic acid hydrogel prepared in Example 2. The storage modulus (G') and loss modulus (G") of the hydrogel show frequency-dependent behavior, which is a typical feature of dynamic hydrogels. The hydrogel exhibits liquid-like behavior at low frequencies, with G' being less than G", however, the hydrogel shows a solid state with G' being greater than G" at high frequencies. Its storage modulus is 4000Pa.
[0082] Example 3
[0083] First, 200 mg HA was dissolved in 20 ml water, and EDAC (287 mg, 1.5 mmol) and NHS (172 mg, 1.5 mmol) with 3 times the molar mass (compared to the carboxylic acid group in HA) were added to the above solution, and 4 M HCl was added to adjust the pH of the solution to 4-5. After two hours of reaction, 337 mg, 1.5 mmol of cysteamine hydrochloride was added. After two days of reaction, 4 M NaOH was added to terminate the reaction. Then 2.3 g, 15 mmol of DTT was dissolved in 5 ml of water and added to the above mixed solution. After the above mixture was reacted under nitrogen protection for 24 hours, 4 M HCl was added to adjust the pH value of the mixed solution to 5. The above solution was dialyzed with a 12000 molecular weight dialysis bag, and the dialyzate was a HCl (pH = 5) solution containing 4 g / l NaCl. After dialysis, the pH of the solution was adjusted to 7 with 1 M NaOH, and then it was quickly placed in liquid nitrogen for cooling. Finally, white foamy thiolated hyaluronic acid (HA-SH) was obtained by freeze drying.
[0084] 1) Synthesis of N-glycine maleamic acid. Glycine (10 g, 0.13 mol) and maleic anhydride (15.68 g, 0.16 mol) were placed in a 500 mL round-bottom flask and 200 mL of glacial acetic acid was added. After magnetic stirring at 30 ° C for 3 h, the mixture was filtered under reduced pressure and the solid was washed with cold water. After vacuum drying, white solid N-glycine maleamic acid was obtained. 2) Synthesis of N-glycine maleimide. N-glycine maleamic acid (10 g, 0.057 mol) was placed in 300 mL of toluene and triethylamine (12.22 g, 0.12 mol) was added. The mixture was refluxed for 2.5 h, and the water generated by the reaction was removed by a Dean-Stark apparatus. After the reaction was completed, the toluene solution was cooled to room temperature and decanted, and the toluene was removed by vacuum rotary evaporation to obtain the triethylamine salt of solid N-glycine maleimide. The solid was dissolved in 100 mL of water at pH = 2 (pH adjusted with hydrochloric acid), extracted with ethyl acetate 3 times, 50 mL each time, and vacuum dried to obtain N-glycine maleimide solid. 3) Maleimide modification of linear PEG end groups. N-glycine maleimide (0.39 g, 2.5 mmol), N,N-dicyclohexylcarbodiimide (0.62 g, 3.0 mmol) and 4-dimethylaminopyridine (0.012 g, 0.1 mmol) were added to a 30 mL dichloromethane solution of PEG10K (1 g, 0.25 mmol). After magnetic stirring for 24 h at room temperature, the filtrate was collected by filtration and the dichloromethane was removed by vacuum rotary evaporation. The sample obtained after the solution was removed was dissolved in isopropanol (30 mL), allowed to stand at 4 ° C for 3 h, and the precipitated solid was collected by vacuum filtration, and the solid was washed with isopropanol and ether respectively. Maleimide PEG (MAL-PEG-MAL) can be obtained after vacuum drying.
[0085] Dissolve 1g HA in 100mL MES buffer solution (0.1M, pH4.7) and stir at room temperature until completely dissolved. Then add 0.474g EDC and 0.285g NHS to the above solution, adjust the pH value of the solution to 5, continue stirring and reacting for 30 minutes, add 0.388g dopamine hydrochloride, add 10mL MES buffer (0.1M, pH5.5) dropwise, stir overnight at room temperature under nitrogen protection, and maintain the pH value at about 5.5. Then, the mixed solution is dialyzed and purified in acidic deionized water in a MWCO3500 dialysis bag for 3 days to remove unreacted dopamine hydrochloride, and finally freeze-dried for 48 hours to obtain a white flocculent grafted product, which is dopamine-modified hyaluronic acid (HA-DA).
[0086] The double network hyaluronic acid hydrogel was prepared according to the following steps: 10wt% HA-SH solution, 6wt% crosslinker MAL-PEG-MAL solution and 15wt% HA-DA solution were prepared with PBS. First, the MAL-PEG-MAL crosslinker was added to HA-SH to obtain a hydrogel composed of HA / PEG, and then the HA-DA solution was added to the above hydrogel, stirred to fully dissolve, and then allowed to stand for crosslinking.
[0087] Figure 6 This is the dynamic frequency scanning curve of the double network hyaluronic acid hydrogel prepared in Example 3. The storage modulus (G') and loss modulus (G") of the hydrogel show frequency-dependent behavior, which is a typical feature of dynamic hydrogels. The hydrogel exhibits liquid-like behavior at low frequencies, with G' being less than G", however, the hydrogel shows a solid state with G' being greater than G" at high frequencies. Its storage modulus is 12 KPa.
[0088] Example 4
[0089] First, 200 mg HA was dissolved in 20 ml water, and EDAC (287 mg, 1.5 mmol) and NHS (172 mg, 1.5 mmol) with 3 times the molar mass (compared to the carboxylic acid group in HA) were added to the above solution, and 4 M HCl was added to adjust the pH of the solution to 4-5. After two hours of reaction, 337 mg, 1.5 mmol of cysteamine hydrochloride was added. After two days of reaction, 4 M NaOH was added to terminate the reaction. Then 2.3 g, 15 mmol of DTT was dissolved in 5 ml of water and added to the above mixed solution. After the above mixture was reacted under nitrogen protection for 24 hours, 4 M HCl was added to adjust the pH value of the mixed solution to 5. The above solution was dialyzed with a 12000 molecular weight dialysis bag, and the dialyzate was a HCl (pH = 5) solution containing 4 g / l NaCl. After dialysis, the pH of the solution was adjusted to 7 with 1 M NaOH, and then it was quickly placed in liquid nitrogen for cooling. Finally, white foamy thiolated hyaluronic acid (HA-SH) was obtained by freeze drying.
[0090] 1) Synthesis of N-glycine maleamic acid. Glycine (10 g, 0.13 mol) and maleic anhydride (15.68 g, 0.16 mol) were placed in a 500 mL round-bottom flask and 200 mL of glacial acetic acid was added. After magnetic stirring at 30 ° C for 3 h, the mixture was filtered under reduced pressure and the solid was washed with cold water. After vacuum drying, white solid N-glycine maleamic acid was obtained. 2) Synthesis of N-glycine maleimide. N-glycine maleamic acid (10 g, 0.057 mol) was placed in 300 mL of toluene and triethylamine (12.22 g, 0.12 mol) was added. The mixture was refluxed for 2.5 h, and the water generated by the reaction was removed by a Dean-Stark apparatus. After the reaction was completed, the toluene solution was cooled to room temperature and decanted, and the toluene was removed by vacuum rotary evaporation to obtain the triethylamine salt of solid N-glycine maleimide. The solid was dissolved in 100 mL of water at pH = 2 (pH adjusted with hydrochloric acid), extracted with ethyl acetate 3 times, 50 mL each time, and vacuum dried to obtain N-glycine maleimide solid. 3) Maleimide modification of linear PEG end groups. N-glycine maleimide (0.39 g, 2.5 mmol), N,N-dicyclohexylcarbodiimide (0.62 g, 3.0 mmol) and 4-dimethylaminopyridine (0.012 g, 0.1 mmol) were added to a 30 mL dichloromethane solution of PEG10K (1 g, 0.25 mmol). After magnetic stirring for 24 h at room temperature, the filtrate was collected by filtration and the dichloromethane was removed by vacuum rotary evaporation. The sample obtained after the solution was removed was dissolved in isopropanol (30 mL), allowed to stand at 4 ° C for 3 h, and the precipitated solid was collected by vacuum filtration, and the solid was washed with isopropanol and ether respectively. Maleimide PEG (MAL-PEG-MAL) can be obtained after vacuum drying.
[0091] Dissolve 1g HA in 100mL MES buffer solution (0.1M, pH4.7) and stir at room temperature until completely dissolved. Then add 0.474g EDC and 0.285g NHS to the above solution, adjust the pH value of the solution to 5, continue stirring and reacting for 30 minutes, add 0.388g dopamine hydrochloride, add 10mL MES buffer (0.1M, pH5.5) dropwise, stir overnight at room temperature under nitrogen protection, and maintain the pH value at about 5.5. Then, the mixed solution is dialyzed and purified in acidic deionized water in a MWCO3500 dialysis bag for 3 days to remove unreacted dopamine hydrochloride, and finally freeze-dried for 48 hours to obtain a white flocculent grafted product, which is dopamine-modified hyaluronic acid (HA-DA).
[0092] The double network hyaluronic acid hydrogel was prepared according to the following steps: 10wt% HA-SH solution, 6wt% crosslinker MAL-PEG-MAL solution and 20wt% HA-DA solution were prepared with PBS. First, the MAL-PEG-MAL crosslinker was added to HA-SH to obtain a hydrogel composed of HA / PEG, and then the HA-DA solution was added to the above hydrogel, stirred to fully dissolve, and then allowed to stand for crosslinking.
[0093] Figure 7 This is the dynamic frequency scanning curve of the double network hyaluronic acid hydrogel prepared in Example 4. The storage modulus (G') and loss modulus (G") of the hydrogel show frequency-dependent behavior, which is a typical feature of dynamic hydrogels. The hydrogel exhibits liquid-like behavior at low frequencies, with G' being less than G", however, the hydrogel shows a solid state with G' being greater than G" at high frequencies. Its storage modulus is 15 KPa.
[0094] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the patent of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A method for preparing a strongly adhesive injectable hyaluronic acid double network hydrogel, characterized in that: The preparation method comprises the following steps: S1. Synthesis of thiolated hyaluronic acid HA-SH; S2. Synthesis of PEG crosslinker MAL-PEG-MAL; S3. Synthesis of dopamine-modified hyaluronic acid HA-DA; S4. Synthesis of strongly adhesive injectable double-network hyaluronic acid hydrogel; The step S1 comprises the following steps: dissolving hyaluronic acid in deionized water, adding carbodiimide and N-hydroxysuccinimide, adjusting the pH to acidic, reacting for 1-3 hours, adding cysteamine hydrochloride, reacting for 36-72 hours, adding dithiothreitol, reacting the mixture under nitrogen protection for 20-28 hours, adjusting the pH to acidic, dialyzing, adjusting the pH of the solution to neutral, quickly cooling it in liquid nitrogen, and freeze-drying to obtain white foamy thiolated hyaluronic acid HA-SH; The step S2 comprises the following steps: 1) Synthesis of N-glycine maleamic acid: glycine and maleic anhydride are placed in glacial acetic acid, and N-glycine maleamic acid is prepared by reaction; 2) Synthesis of N-glycine maleimide: the above-mentioned N-glycine maleamic acid is placed in toluene, triethylamine is added, refluxed, and vacuum rotary evaporation is performed to prepare triethylamine salt of solid N-glycine maleimide, which is dissolved in a solution with pH=2, extracted with ethyl acetate, and vacuum dried to prepare N-glycine maleimide; 3) Maleimide modification of linear PEG end groups: N-glycine maleimide, N,N-dicyclohexylcarbodiimide and 4-dimethylaminopyridine are added to a dichloromethane solution of PEG, dichloromethane is removed by vacuum rotary evaporation after the reaction, the sample is dissolved in isopropanol, the solid is collected after standing, the solid is washed with isopropanol and ether, and the PEG crosslinker MAL-PEG-MAL is obtained after vacuum drying; The step S3 comprises the following steps: dissolving hyaluronic acid HA in MES buffer solution, stirring at room temperature until completely dissolved, then adding carbodiimide and N-hydroxysuccinimide to the above solution, adjusting the pH value of the solution to acidic, continuing to stir the reaction, adding dopamine hydrochloride, adding MES buffer dropwise, stirring at room temperature overnight under nitrogen protection, maintaining the pH value at weak acidity, then dialyzing the mixed solution in acidic deionized water to purify and remove unreacted dopamine hydrochloride, and finally freeze-drying to obtain a white flocculent grafted product, i.e., dopamine-modified hyaluronic acid HA-DA, which is stored in a refrigerator; The step S4 comprises the following steps: adding the MAL-PEG-MAL crosslinker to HA-SH to obtain a hydrogel composed of HA / PEG, HA-SH-MAL-PEG-MAL, and then adding the HA-DA solution to the hydrogel, stirring to fully dissolve and then standing to crosslink; The hydrogel uses maleimidized PEG to crosslink thiolated HA as the first layer of hyaluronic acid crosslinking network, and uses hyaluronic acid grafted with dopamine to crosslink hyaluronic acid through oxidative self-polymerization of dopamine as the second layer of hyaluronic acid crosslinking network; The mass average molecular weight range of the hyaluronic acid HA is 100000-300000 g / mol; The molar ratio of cysteamine hydrochloride to HA is 1000 / 1-5000 / 1; The molar ratio of dithiothreitol to HA is 10000 / 1-50000 / 1; The molar ratio of glycine to maleic anhydride is 1 / 1-1 / 1.5; The molar ratio of triethylamine to N-glycine maleamic acid is 3 / 1-1 / 1; The molar ratio of N-glycine maleimide, N,N-dicyclohexylcarbodiimide, 4-dimethylaminopyridine and PEG is 2.5 / 3.0 / 0.1 / 0.25; The mass average molecular weight range of the PEG is 5000-15000 g / mol; The molar ratio of dopamine hydrochloride to HA is 500 / 1-300 / 1; The mass ratio of HA-SH / MAL-PEG-MAL is 1 / 1-10 / 1; The mass ratio of HA-SH-MAL-PEG-MAL / HA-DA is 0.5 / 1-2 / 1.
